ZOTA HEALTH CARE LIMITED (ZOTA) financials

ZOTA HEALTH CARE LIMITED (ZOTA) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Zota Health Care Limited is a renowned pharmaceutical company that manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over-the-counter (OTC) products across boundaries into the semi-regulated and regulated markets of Asian Countries markets of African Countries, Russian Countries & Latin America.[1]

Market Cap: ₹4,918Cr.
Current Price: ₹1,420
Stock P/E: 200
ROE: 4.74%
ROCE: 6.68%
Book Value: ₹256
Dividend Yield: 0.07%
52W High / Low: ₹1,740/1,022

In Jun 2026, ZOTA HEALTH CARE LIMITED (ZOTA) reported sales ₹127.03 Cr and net profit ₹1.90 Cr.

Annual TTM: sales ₹456 Cr, net profit ₹24 Cr.

Shareholding: Promoters 49.38% (Jun 2026), FIIs 7.92% (Jun 2026), DIIs 6.75% (Jun 2026), Public 35.96% (Jun 2026), No. of Shareholders 14,678% (Jun 2026).

ZOTA quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	59.01	68.13	77.93	78.01	99.42	108.88	120.70	127.03
Expenses	55.77	66.82	73.99	70.86	88.62	100.61	115.35	126.80
Operating Profit	3.24	1.31	3.94	7.15	10.80	8.27	5.35	0.23
OPM %	5.49%	1.92%	5.06%	9.17%	10.86%	7.60%	4.43%	0.18%
Other Income	0.97	1.69	1.50	2.23	3.27	3.80	3.11	3.94
Interest	0.52	0.04	0.08	0.04	0.09	0.05	0.08	0.30
Depreciation	0.73	0.82	0.94	0.80	0.91	0.99	1.25	1.27
Profit before tax	2.96	2.14	4.42	8.54	13.07	11.03	7.13	2.60
Tax %	20.61%	2.80%	41.18%	30.91%	24.18%	45.60%	14.45%	27.31%
Net Profit	2.35	2.08	2.60	5.90	9.91	6.01	6.09	1.90
EPS in Rs	0.86	0.75	0.91	1.98	3.23	1.78	1.76	0.55
Raw PDF	—	—	—	—	—	—	—	—

ZOTA profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	95	106	131	138	166	256	407	456
Expenses	90	105	116	130	160	245	375	431
Operating Profit	5	1	15	8	6	11	32	25
OPM %	4.8%	0.6%	12%	6%	3.7%	4.5%	8%	5%
Other Income	2	2	2	3	2	5	12	14
Interest	0	0	0	0	0	1	0	1
Depreciation	2	3	3	2	3	3	4	4
Profit before tax	4	-0	14	9	5	12	40	34
Tax %	29%	-47%	25%	24%	31%	27%	30%	—
Net Profit	3	-0	11	7	3	9	28	24
EPS in Rs	1.12	-0.07	4.21	2.62	1.31	3.01	8.06	7.32
Dividend Payout %	89%	-1,535%	36%	38%	76%	33%	12%	—

ZOTA balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	18	25	25	25	25	26	29	35
Reserves	51	44	42	66	69	96	289	854
Borrowings	0	0	0	0	0	15	0	22
Other Liabilities	21	20	19	34	30	37	62	107
Total Liabilities	90	88	86	125	125	173	380	1,017
Fixed Assets	10	15	14	13	11	12	12	34
CWIP	2	0	0	0	3	5	6	0
Investments	16	14	10	35	10	7	116	548
Other Assets	63	59	62	78	101	150	246	435
Total Assets	90	88	86	125	125	173	380	1,017

ZOTA cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	-3	6	-1	14	-10	-30	-22	-46
Cash from Investing Activity	9	-4	4	-27	13	-9	-148	-515
Cash from Financing Activity	-6	-3	-2	14	-4	38	171	561
Net Cash Flow	-1	-1	1	1	-1	-1	1	0
Free Cash Flow	-6	-1	-2	12	-14	-35	-26	-66
CFO/OP	-12%	146%	-116%	113%	-102%	-460%	-164%	-110%

ZOTA shareholding pattern (%)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	62.40%	62.02%	59.72%	57.42%	55.81%	50.64%	49.38%	49.38%
FIIs	0.01%	0.24%	0.87%	3.82%	3.49%	8.09%	8.21%	7.92%
DIIs	0.99%	1.03%	3.08%	4.25%	4.95%	7.22%	6.40%	6.75%
Public	36.60%	36.71%	36.33%	34.52%	35.75%	34.06%	36.00%	35.96%
No. of Shareholders	8,937	9,763	10,389	10,354	11,855	13,185	14,005	14,678

ZOTA key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	95	112	99	107	115	162	147	158
Inventory Days	207	139	139	116	148	139	138	131
Days Payable	103	82	77	76	102	107	107	121
Cash Conversion Cycle	199	169	161	147	161	194	178	168
Working Capital Days	175	152	143	112	153	172	177	155
ROCE %	11%	6%	-2%	18%	9%	5%	6%	7%

ZOTAUpdated 15 Oct 2026, 7:23

Zota Health Care Limited

ZOTAUpdated 15 Oct 2026, 7:23

Market Cap

₹4,918Cr.

Current Price

₹1,420

High / Low

₹1,740/1,022

Stock P/E

200

ROE4.74%

ROCE6.68%

Book Value₹256

Face Value₹10.0

Dividend Yield0.07%

About

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	35.25	0.05	34.64	0.36	0.55	0.37	43.24	0.21	0.08
Sep 2023	41.15	0.25	38.06	0.63	0.77	2.7	33.7	1.79	0.69
Dec 2023	42.83	0	40.71	0.38	0.83	1.67	30.54	1.16	0.45
Mar 2024	47.35	0.06	46.97	0.69	0.86	0.15	-46.67	0.22	0.09
Jun 2024	52.2	0.42	49.25	0.47	0.68	2.32	31.9	1.58	0.6
Sep 2024	59.01	0.52	55.77	0.97	0.73	2.96	20.61	2.35	0.86
Dec 2024	68.13	0.04	66.82	1.69	0.82	2.14	2.8	2.08	0.75
Mar 2025	77.93	0.08	73.99	1.5	0.94	4.42	41.18	2.6	0.91
Jun 2025	78.01	0.04	70.86	2.23	0.8	8.54	30.91	5.9	1.98
Sep 2025	99.42	0.09	88.62	3.27	0.91	13.07	24.18	9.91	3.23
Dec 2025	108.88	0.05	100.61	3.8	0.99	11.03	45.6	6.01	1.78
Mar 2026	120.7	0.08	115.35	3.11	1.25	7.13	14.45	6.09	1.76
Jun 2026	127.03	0.3	126.8	3.94	1.27	2.6	27.31	1.9	0.55

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	56	1	47	0	2	6	33	4	2.12
Mar 2016	64	1	55	0	1	8	34	5	2.54
Mar 2017	70	1	60	0	1	8	34	6	2.76
Mar 2018	77	0	66	2	1	11	36	7	2.96
Mar 2019	85	0	77	2	1	8	29	6	2.26
Mar 2020	95	0	90	2	2	4	29	3	1.12
Mar 2021	106	0	105	2	3	0	-47	0	-0.07
Mar 2022	131	0	116	2	3	14	25	11	4.21
Mar 2023	138	0	130	3	2	9	24	7	2.62
Mar 2024	166	0	160	2	3	5	31	3	1.31
Mar 2025	256	1	245	5	3	12	27	9	3.01
Mar 2026	407	0	375	12	4	40	30	28	8.06
TTM	456	1	431	14	4	34	—	24	7.32

Shareholding pattern

As of Jun 2026%

Holder	Share
Promoters	49.38%
FIIs	7.92%
DIIs	6.75%
Public	35.96%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Sep 2023	66.16%	0.02%	0%	33.83%
Dec 2023	66.15%	0%	0%	33.85%
Mar 2024	66.15%	0%	0%	33.85%
Jun 2024	64.44%	0.01%	0%	35.55%
Sep 2024	62.4%	0.01%	0.99%	36.6%
Dec 2024	62.02%	0.24%	1.03%	36.71%
Mar 2025	59.72%	0.87%	3.08%	36.33%
Jun 2025	57.42%	3.82%	4.25%	34.52%
Sep 2025	55.81%	3.49%	4.95%	35.75%
Dec 2025	50.64%	8.09%	7.22%	34.06%
Mar 2026	49.38%	8.21%	6.4%	36%
Jun 2026	49.38%	7.92%	6.75%	35.96%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	14	4	5	15	38	8	0	0	30	38
Mar 2016	14	7	2	20	44	7	1	0	36	44
Mar 2017	14	13	4	23	54	7	2	0	45	54
Mar 2018	18	52	0	22	92	10	0	26	56	92
Mar 2019	18	51	0	21	90	10	2	16	63	90
Mar 2020	25	44	0	20	88	15	0	14	59	88
Mar 2021	25	42	0	19	86	14	0	10	62	86
Mar 2022	25	66	0	34	125	13	0	35	78	125
Mar 2023	25	69	0	30	125	11	3	10	101	125
Mar 2024	26	96	15	37	173	12	5	7	150	173
Mar 2025	29	289	0	62	380	12	6	116	246	380
Mar 2026	35	854	22	107	1017	34	0	548	435	1017

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	4	-1	-4	0
Mar 2016	5	-1	-3	1
Mar 2017	3	-2	-2	-1
Mar 2018	-4	-26	33	2
Mar 2019	-3	9	-6	-1
Mar 2020	6	-4	-3	-1
Mar 2021	-1	4	-2	1
Mar 2022	14	-27	14	1
Mar 2023	-10	13	-4	-1
Mar 2024	-30	-9	38	-1
Mar 2025	-22	-148	171	1
Mar 2026	-46	-515	561	0

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	77	90	88	109	95	112	99	107	115	162	147	158
Inventory Days	175	141	193	174	207	139	139	116	148	139	138	131
Days Payable	116	126	148	118	103	82	77	76	102	107	107	121
Cash Conversion Cycle	135	105	133	165	199	169	161	147	161	194	178	168
Working Capital Days	67	85	106	151	175	152	143	112	153	172	177	155
ROCE %	32%	36%	33%	23%	11%	6%	-2%	18%	9%	5%	6%	7%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of ZOTA HEALTH CARE LIMITED (ZOTA)?

The reported market capitalisation for ZOTA HEALTH CARE LIMITED (ZOTA) is ₹4,918Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of ZOTA?

The current price shown for ZOTA HEALTH CARE LIMITED (ZOTA) on Fincrux is ₹1,420 with a 52-week high/low of ₹1,740/1,022.

What is the P/E ratio of ZOTA HEALTH CARE LIMITED (ZOTA)?

The stock P/E for ZOTA HEALTH CARE LIMITED (ZOTA) is 200 on Fincrux, with ROE at 4.74% and ROCE at 6.68%.

What were ZOTA latest quarterly results?

For Jun 2026, ZOTA HEALTH CARE LIMITED (ZOTA) reported sales ₹127.03 Cr and net profit ₹1.90 Cr (figures in ₹ crore unless noted).

What are ZOTA annual sales and net profit?

For TTM, ZOTA HEALTH CARE LIMITED (ZOTA) shows sales of ₹456 Cr and net profit of ₹24 Cr on the Fincrux profit & loss statement.

Who owns ZOTA HEALTH CARE LIMITED (ZOTA)?

Latest shareholding for ZOTA HEALTH CARE LIMITED (ZOTA) on Fincrux: Promoters 49.38% (Jun 2026), FIIs 7.92% (Jun 2026), DIIs 6.75% (Jun 2026), Public 35.96% (Jun 2026), No. of Shareholders 14,678% (Jun 2026).

Where can I find ZOTA HEALTH CARE LIMITED (ZOTA) financials?

ZOTA HEALTH CARE LIMITED (ZOTA) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show ZOTA balance sheet and cash flow?

Yes. The ZOTA HEALTH CARE LIMITED (ZOTA) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 15 October 2026 at 7:23